Helicobacter priori lipopolysaccharide binds to CD14 and stimulates release of intefleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes

Infection and Immunity

Volumn 66, Issue 11, 1998, Pages 5357-5363

  Bliss Jr , Charles M ^a   Golenbock, Douglas T ^a   Keates, Sarah ^b   Linevsky, Joanne K ^a   Kelly, Ciarán P ^b,c  

^a BOSTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Israel Deaconess Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; ALPHA CHEMOKINE; CXCL5 PROTEIN, HUMAN; DRUG DERIVATIVE; ENDOTOXIN RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LIPID A;

ARTICLE; CELL INVASION; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LAMINA PROPRIA; LEUKOCYTE MIGRATION; LYMPHOCYTE COUNT; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; STOMACH MUCOSA; TRANSCRIPTION REGULATION; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RHODOBACTER SPHAEROIDES; UPREGULATION;

ANTIGENS, CD14; CHEMOKINE CCL2; CHEMOKINES, CXC; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; LIPID A; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTORS, IMMUNOLOGIC; RHODOBACTER SPHAEROIDES; UP-REGULATION;

EID: 0032209298     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.11.5357-5363.1998     Document Type: Article

References (11)

1. Aihara, M., D. Tsuchimoto, H. Takizawa, A. Azuma, H. Wakebe, Y. Ohmoto, K. Imagawa, M. Kikuchi, N. Mukaida, and K. Matsushima. 1997. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect. Immun. 65:3218-3224.
2. Anonymous. 1994. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69.
3. Anonymous. 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61:1-241.
4. Anonymous. 1997. The report of the Digestive Health Initiative international conference on Helicobacter pylori. Gastroenterology 113:S1-S169.
5. Appelmelk, B. J., R. Negrini, A. P. Moran, and E. J. Kuipers. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 5:70-73.
6. Aspinall, G. O., M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran. 1996. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 35:2489-2497.
7. Baggiolini, M, P. Loetscher, and B. Moser. 1995. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17:103-108.
8. Ben-Baruch, A., D. F. Michiel, and J. J. Oppenheim. 1996. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270: 11703-11706.
9. Birkholz, S, U. Knipp, C. Nietzki, R. J. Adamek, and W. Opferkuch. 1993. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol. Med. Microbiol. 6:317-324.
10. Blaser, M. J. 1995. The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment. Pharmacol. Ther. 9(Suppl. 1):27-30.
11. Calam, J. 1995. Pathogenic mechanisms, p. 487-506. In J. Calam (ed.), Helicobacter pylori. Bailliere Tindall, London, United Kingdom.